Alignment Healthcare, Inc. - Common Stock (ALHC)

22.54
+0.82 (3.78%)
NASDAQ · Last Trade: Apr 30th, 8:23 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Alignment Healthcare (NASDAQ:ALHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 33.3% year on ye...
Via StockStory · April 30, 2026
Alignment Healthcare (NASDAQ:ALHC) Slides as Revenue Miss and Conservative Guidance Overshadow Earnings Beatchartmill.com
Via Chartmill · April 30, 2026
Alignment Healthcare Inc. (NASDAQ:ALHC) Scores Outstanding 9/10 Technical and Setup Ratings in Breakout Screening Strategychartmill.com
Via Chartmill · April 30, 2026
Alignment Healthcare Earnings: What To Look For From ALHC
Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting results this Thursday after market close. Here’s what to expect. Alignment Heal...
Via StockStory · April 28, 2026
2 Russell 2000 Stocks on Our Buy List and 1 We Question
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via StockStory · April 24, 2026
Alignment Healthcare Inc (NASDAQ:ALHC) Shows Strong Growth Momentum and Bullish Technical Setupchartmill.com
Via Chartmill · April 16, 2026
Alignment Healthcare Inc. (NASDAQ:ALHC) Beats Q4 Estimates but Cautious 2026 Outlook Dents Shareschartmill.com
Via Chartmill · February 26, 2026
3 Reasons Investors Love Alignment Healthcare (ALHC)
Alignment Healthcare’s 21.4% return over the past six months has outpaced the S&P 500 by 16.6%, and its stock price has climbed to $21.00 per share. This per...
Via StockStory · April 23, 2026
An Alignment Healthcare (ALHC) Insider Sold 30,000 Shares for $626,000fool.com
This tech-enabled healthcare provider for seniors reported a notable insider sale amid ongoing portfolio management activity.
Via The Motley Fool · April 20, 2026
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
Via StockStory · April 7, 2026
Gapping stocks in Tuesday's sessionchartmill.com
Via Chartmill · April 7, 2026
Curious about the stocks that are showing activity after the closing bell on Monday?chartmill.com
Via Chartmill · April 6, 2026
A Look Back at Health Insurance Providers Stocks’ Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how health insurance ...
Via StockStory · April 2, 2026
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Knowfool.com
Medicare Advantage specialist Alignment Healthcare reported a notable insider sale as its leadership continues to adjust personal holdings.
Via The Motley Fool · March 24, 2026
2 Cash-Producing Stocks with Promising Prospects and 1 Facing Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via StockStory · March 20, 2026
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...
Via StockStory · March 16, 2026
3 Cash-Heavy Stocks Worth Your Attention
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. Eve...
Via StockStory · March 10, 2026
1 High-Flying Stock for Long-Term Investors and 2 We Question
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Via StockStory · March 1, 2026
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. 
Via StockStory · February 27, 2026
Alignment (ALHC) Q4 2025 Earnings Call Transcriptfool.com
Alignment (ALHC) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Alignment Healthcare (NASDAQ:ALHC) Surprises With Q4 CY2025 Sales
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 44.4% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.22 billion was less impressive, coming in 1.9% below analysts’ estimates. Its GAAP loss of $0.05 per share was 67.1% above analysts’ consensus estimates.
Via StockStory · February 26, 2026
Alignment Healthcare (ALHC) Reports Q4: Everything You Need To Know Ahead Of Earnings
Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting results this Thursday after market hours. Here’s what investors should know.
Via StockStory · February 24, 2026
2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · February 19, 2026
Humana Shares Plunge as $3.5 Billion Star Ratings Headwind Forces Conservative 2026 Guidance
Humana Inc. (NYSE:HUM) shares experienced a sharp sell-off this week after the health insurance giant issued a surprisingly conservative financial outlook for 2026. The company warned investors that a massive $3.5 billion net headwind stemming from a decline in Medicare Advantage (MA) Star Ratings would severely compress margins,
Via MarketMinute · February 13, 2026
1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Via StockStory · February 12, 2026